Study guide

9.3 Days Supply Calculations, Package Size Verification, and Final Label Matching

PTCB Technician Product Verification TPV

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Tech-Check-Tech Verification Fundamentals

1.1 About the PTCB TPV Certificate Exam 1.2 Tech-Check-Tech (TCT) Scope, Regulations, and Quality Assurance 1.3 Systematic Verification Protocol & Visual Inspection Steps

2 Chapter 2: Drug Name Verification & Brand/Generic Identification

2.1 Brand vs Generic Mapping, USAN Stems, and Orange Book Therapeutic Equivalence 2.2 Salt Forms and Active Ingredient Verification 2.3 Manufacturer-Specific Identification, Visual Cues, and Color Codes

3 Chapter 3: Auxiliary Labels, REMS & Controlled Substances

3.1 Auxiliary Warning Labels and Mandatory Patient Counseling Triggers 3.2 REMS Programs and Restricted Distribution Medications 3.3 Controlled Substance Scheduling, Refill Restrictions, and C-II Exact Counts

4 Chapter 4: Dosage Forms, Release Mechanisms & Administration Routes

4.1 Modified-Release Formulations (ER, XL, SR, DR, CR) and "Do Not Crush" Rules 4.2 Route of Administration Verification: Ophthalmic vs Otic, Oral vs Topical vs Transdermal 4.3 Specialized Delivery Systems: Inhalers (MDI/DPI), ODTs, Solutions vs Suspensions

5 Chapter 5: Strength Verification & Pharmaceutical Calculations

5.1 Unit Conversions (mcg, mg, g) and Preventing Leading/Trailing Zero Errors 5.2 Percentage Strengths, Ratio Strengths, and Liquid Concentrations (mg/mL) 5.3 Electrolyte Equivalents (mEq vs mg) and Combination Product Strength Verification

6 Chapter 6: High-Alert Medications & Safety Protocols

6.1 ISMP High-Alert Medications and Independent Double-Check Protocols 6.2 Insulin Formulations, Concentrations (U-100, U-500, U-200, U-300), and Pen/Vial Math 6.3 Concentrated Electrolytes, Opioids, Neuromuscular Blockers, and Oral Methotrexate

7 Chapter 7: Look-Alike / Sound-Alike (LASA) Medications

7.1 FDA and ISMP Tall-Man Lettering Principles 7.2 High-Risk Community/Ambulatory LASA Pairs 7.3 High-Risk Institutional/Hospital LASA Pairs & Packaging Traps

8 Chapter 8: Packaging, Expiration, Storage & Special Handling

8.1 Expiration Date Interpretation and Multi-Dose Vial Beyond-Use Dating (BUD) 8.2 Packaging Integrity, Moisture/Light Sensitivity, and FDA Recall Classes 8.3 Temperature Storage Ranges and Vaccine Cold Chain Integrity 8.4 USP <800> Hazardous Drug Identification and Handling Precautions

9 Chapter 9: NDC Conversion, Repackaging & Final Dispensing Checks

9.1 NDC 10-Digit to 11-Digit Conversion (5-4-2 Standardization) 9.2 Unit-Dose Repackaging Standards and USP <795> BUD Guidelines 9.3 Days Supply Calculations, Package Size Verification, and Final Label Matching

9.3 Days Supply Calculations, Package Size Verification, and Final Label Matching

Key Takeaways Explain This Topic AI

Days supply calculations determine the duration a dispensed quantity will last and are calculated by dividing the total quantity dispensed by the total daily dose.

Ophthalmic and otic drop calculations use a standard insurance benchmark of 20 drops per milliliter (gtt/mL), meaning a 5 mL bottle contains 100 drops and a 10 mL bottle contains 200 drops.

Insulin pen days supply must account for both mathematical volume and open-pen room-temperature Beyond-Use Date limits (e.g., 28 days for Lantus/Humalog, 42 days for Levemir, 56 days for Toujeo/Tresiba).

Inhaler days supply is calculated by dividing the total rated canister actuations by the maximum daily puffs prescribed.

The 12-Point Label Verification Checklist requires systematic inspection of patient name, prescriber, date filled, Rx number, drug name/strength/form, SIG directions, quantity, refills, NDC/manufacturer, BUD/expiration date, pharmacy details, and mandatory auxiliary warning statements.

Last updated: August 2026

Days Supply Calculations, Package Size Verification, and Final Label Matching

Core Verification Rule: Mathematical accuracy and systematic visual comparison form the final barrier against dispensing errors. Verifying technicians must independently verify days supply calculations for non-standard dosage forms (liquids, drops, inhalers, insulins) and execute a structured 12-point label inspection before releasing any medication for patient handoff.

Calculating the correct days supply and verifying container package sizes are critical technical competencies in both community and institutional pharmacy practice. An incorrect days supply calculation leads to third-party insurance claim rejections, early refill audit chargebacks, patient under- or overdosing, and premature therapy termination.

1. Core Principles of Days Supply Calculations

The universal mathematical formula for calculating days supply is: Days Supply = Total Quantity Dispensed / Total Daily Dose (Units, Doses, or Volume / Day)

While solid oral tablets and capsules follow straightforward unit division, specialized dosage forms require specific conversion benchmarks and packaging rules.

  • 2. Specialized Dosage Form Calculation Protocols
  • A. Ophthalmic and Otic Drops (Solutions and Suspensions)

In pharmacy mathematics, standard medical droppers vary between 15 and 20 drops per milliliter ( g t t / m L gtt/mL g tt / m L ). However, for prescription billing, third-party payers (including Medicare Part D and commercial PBMs) and state boards universally enforce the 20 drops/mL standard benchmark (unless a manufacturer explicitly specifies otherwise). Standard Dropper Calibration: 1 mL = 20 Drops (gtt)

Bottle Size (mL) Total Drops per Bottle ( m L × 20 mL \times 20 m L × 20 ) Example Dosing Regimen Daily Usage Days Supply Calculation

2.5 mL 50 drops 50\text{ drops} 50 drops 1 drop OD once daily 1 drop/day 1\text{ drop/day} 1 drop/day 50 / 1 = 50 days 50 / 1 = \mathbf{50\text{ days}} 50/1 = 50 days

5.0 mL 100 drops 100\text{ drops} 100 drops 1 drop OU BID (both eyes twice daily) 1 × 2 × 2 = 4 drops/day 1 \times 2 \times 2 = 4\text{ drops/day} 1 × 2 × 2 = 4 drops/day 100 / 4 = 25 days 100 / 4 = \mathbf{25\text{ days}} 100/4 = 25 days

10.0 mL 200 drops 200\text{ drops} 200 drops 2 drops OS TID (left eye 3 times daily) 2 × 3 = 6 drops/day 2 \times 3 = 6\text{ drops/day} 2 × 3 = 6 drops/day 200 / 6 = 33.3 → 33 days 200 / 6 = 33.3 \rightarrow \mathbf{33\text{ days}} 200/6 = 33.3 → 33 days

15.0 mL 300 drops 300\text{ drops} 300 drops 1 drop OU QID (both eyes 4 times daily) 1 × 2 × 4 = 8 drops/day 1 \times 2 \times 4 = 8\text{ drops/day} 1 × 2 × 4 = 8 drops/day 300 / 8 = 37.5 → 37 days 300 / 8 = 37.5 \rightarrow \mathbf{37\text{ days}} 300/8 = 37.5 → 37 days

Important

Ophthalmic Latin Abbreviations Check:

  • OD (Oculus Dexter): Right eye (1 eye)
  • OS (Oculus Sinister): Left eye (1 eye)
  • OU (Oculus Uterque): Both eyes (2 eyes → \rightarrow → multiply drop count by 2!)
  • Worked Example: Glaucoma Drops

Prescription: Latanoprost 0.005% ophthalmic solution. Instill 1 drop into both eyes (OU) every evening at bedtime. Dispense 1 bottle (2.5 mL).

Total Drops Dispensed: 2.5 mL × 20 drops/mL = 50 drops 2.5\text{ mL} \times 20\text{ drops/mL} = 50\text{ drops} 2.5 mL × 20 drops/mL = 50 drops

Daily Dose: 1 drop × 2 eyes × 1 time/day = 2 drops/day 1\text{ drop} \times 2\text{ eyes} \times 1\text{ time/day} = 2\text{ drops/day} 1 drop × 2 eyes × 1 time/day = 2 drops/day

Days Supply: 50 drops 2 drops/day = 25 days supply \frac{50\text{ drops}}{2\text{ drops/day}} = \mathbf{25\text{ days supply}} 2 drops/day 50 drops ​ = 25 days supply

B. Inhalers (MDIs and DPIs)

Metered-dose inhalers (MDIs) and dry powder inhalers (DPIs) contain a fixed number of metered actuations (puffs) per canister or device. Days supply is calculated using the manufacturer's rated actuation capacity: Days Supply = Total Number of Actuations in Device / Total Daily Puffs

Inhaler Product Device Type Actuation Capacity Example SIG Directions Daily Puffs Days Supply

ProAir HFA / Ventolin HFA MDI (Albuterol) 200 actuations (8.5 g) Inhale 2 puffs Q4-6H PRN (Max: 2 puffs QID) 2 × 4 = 8 puffs/day 2 \times 4 = 8\text{ puffs/day} 2 × 4 = 8 puffs/day 200 / 8 = 25 days 200 / 8 = \mathbf{25\text{ days}} 200/8 = 25 days

Flovent HFA 110 mcg MDI (Fluticasone) 120 actuations (12 g) Inhale 2 puffs BID 2 × 2 = 4 puffs/day 2 \times 2 = 4\text{ puffs/day} 2 × 2 = 4 puffs/day 120 / 4 = 30 days 120 / 4 = \mathbf{30\text{ days}} 120/4 = 30 days

Advair Diskus 250/50 DPI (Fluticasone/Salmeterol) 60 blister doses Inhale 1 blister dose BID 1 × 2 = 2 doses/day 1 \times 2 = 2\text{ doses/day} 1 × 2 = 2 doses/day 60 / 2 = 30 days 60 / 2 = \mathbf{30\text{ days}} 60/2 = 30 days

Symbicort 160/4.5 MDI (Budesonide/Formoterol) 120 actuations (10.2 g) Inhale 2 puffs BID 2 × 2 = 4 puffs/day 2 \times 2 = 4\text{ puffs/day} 2 × 2 = 4 puffs/day 120 / 4 = 30 days 120 / 4 = \mathbf{30\text{ days}} 120/4 = 30 days

Spiriva HandiHaler DPI Capsule Inhaler 30 capsules Inhale contents of 1 capsule daily 1 capsule/day 1\text{ capsule/day} 1 capsule/day 30 / 1 = 30 days 30 / 1 = \mathbf{30\text{ days}} 30/1 = 30 days

C. Insulin Pens and Multi-Dose Vials

Standard insulin formulations are manufactured at a concentration of U-100 (100 units/mL) .

A standard insulin pen contains 3 mL = 300 units of insulin.

A standard box of pens contains 5 pens = 15 mL = 1,500 units total.

A standard insulin vial contains 10 mL = 1,000 units total. Total Units = Volume in mL × Concentration (Units/mL)

The Open-Pen Beyond-Use Date (BUD) Rule in Days Supply

When calculating days supply for insulin, technicians must factor in the room-temperature stability limit after first puncture/use. Regardless of remaining volume, the pen must be discarded once the open BUD is reached!

  • Insulin Product Active Ingredient Concentration Pen Volume Unopened Storage Opened Room Temp BUD
  • Lantus SoloStar Glargine U-100 (100 u/mL) 3 mL (300 u) Refrigerate (2°–8°C) 28 Days
  • Humalog KwikPen Lispro U-100 (100 u/mL) 3 mL (300 u) Refrigerate (2°–8°C) 28 Days
  • NovoLog FlexPen Aspart U-100 (100 u/mL) 3 mL (300 u) Refrigerate (2°–8°C) 28 Days
  • Levemir FlexTouch Detemir U-100 (100 u/mL) 3 mL (300 u) Refrigerate (2°–8°C) 42 Days
  • Toujeo SoloStar Glargine U-300 (300 u/mL) 1.5 mL (450 u) Refrigerate (2°–8°C) 56 Days
  • Tresiba FlexTouch Degludec U-100 / U-200 3 mL (300 / 600 u) Refrigerate (2°–8°C) 56 Days

Caution

Critical Insulin Days Supply Trap: If a patient injects 10 units of Lantus U-100 once daily from a 3 mL pen (300 units total):

Mathematical calculation: 300 units / 10 units/day = 30 days 300\text{ units} / 10\text{ units/day} = 30\text{ days} 300 units /10 units/day = 30 days .

Clinical BUD limit: Lantus pens must be discarded 28 days after opening.

True Billable Days Supply: 28 days ! Submitting 30 days will cause an audit chargeback or patient under-dosing if they discard the pen at 28 days.

D. Reconstituted Oral Liquid Suspensions

Antibiotic oral powders require reconstitution with Purified Water prior to dispensing. Technicians must verify total volume dispensed, daily dosage volume, and the post-reconstitution BUD:

Formula: Days Supply = Total Volume Dispensed (mL) Daily Dose Volume (mL/day) \text{Days Supply} = \frac{\text{Total Volume Dispensed (mL)}}{\text{Daily Dose Volume (mL/day)}} Days Supply = Daily Dose Volume (mL/day) Total Volume Dispensed (mL) ​

  • Antibiotic Suspension Standard Concentration Storage After Reconstitution Post-Reconstitution BUD
  • Amoxicillin 125, 200, 250, 400 mg/5 mL Refrigeration preferred (stable at room temp) 14 Days
  • Augmentin (Amox/Clav) 125, 200, 250, 400 mg/5 mL Refrigerate strictly (2°–8°C) 10 Days
  • Cephalexin (Keflex) 125, 250 mg/5 mL Refrigerate strictly (2°–8°C) 14 Days
  • Cefdinir (Omnicef) 125, 250 mg/5 mL Room temperature (DO NOT refrigerate!) 10 Days
  • Azithromycin (Zithromax) 100, 200 mg/5 mL Room temperature (DO NOT refrigerate!) 10 Days
  • Worked Example: Pediatric Amoxicillin

Prescription: Amoxicillin 250 mg/5 mL suspension. Give 1 teaspoonful (5 mL) by mouth three times daily (TID) for 10 days. Dispense 1 bottle (150 mL).

Daily Volume: 5 mL × 3 = 15 mL/day 5\text{ mL} \times 3 = 15\text{ mL/day} 5 mL × 3 = 15 mL/day

Total Volume Needed: 15 mL/day × 10 days = 150 mL 15\text{ mL/day} \times 10\text{ days} = 150\text{ mL} 15 mL/day × 10 days = 150 mL

Days Supply: 150 mL 15 mL/day = 10 days supply \frac{150\text{ mL}}{15\text{ mL/day}} = \mathbf{10\text{ days supply}} 15 mL/day 150 mL ​ = 10 days supply

Verification Check: Confirm 150 mL bottle reconstituted with exact volume of water, label shows 14-day refrigerated BUD, and "Refrigerate" + "Shake Well" auxiliary stickers are affixed.

3. The 12-Point Comprehensive Label Verification Checklist

Before any filled prescription is cleared for final dispensing, the verifying technician must execute a systematic 12-point inspection comparing the physical container, prescription label, stock bottle, and electronic profile: ┌────────────────────────────────────────────────────────────────────────┐

  • │ THE 12-POINT FINAL LABEL VERIFICATION CHECKLIST │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 1. Patient Demographics │ Full legal name and DOB match order. │
  • │ 2. Prescriber Information │ Prescriber name, credentials, NPI/DEA. │
  • │ 3. Date Filled & Origin │ Date prepared and original Rx date. │
  • │ 4. Prescription (Rx) # │ Unique serial number matches system. │
  • │ 5. Drug Name & Strength │ Generic name, brand equivalent, potency. │
  • │ 6. Dosage Form & Route │ Tablet, ER capsule, suspension, etc. │
  • │ 7. Directions for Use │ Action verb, dose, route, frequency (SIG).│
  • │ 8. Quantity Dispensed │ Exact numerical count, mL, or grams. │
  • │ 9. Refills Remaining │ Authorized refills and expiration date. │
  • │ 10. NDC & Manufacturer │ 11-digit standardized code matches bottle.│
  • │ 11. BUD & Expiration Date │ 1-year dispense limit or specific BUD. │
  • │ 12. Cautionary Warnings │ Federal transfer warning & auxiliary tags.│
  • └────────────────────────────────────────────────────────────────────────┘
  • Detailed Checklist Element Standards

Patient Demographics: Verify correct spelling of patient's first and last name, date of birth (DOB), and verify that family members with identical last names or similar first names (e.g., Senior vs. Junior) are not cross-dispensed.

Prescriber Information: Confirm prescriber's full name, clinic location, and active licensing/DEA authority for controlled substances.

Date Filled & Date of Origin: Confirm date filled against prescription issue date to ensure validity (e.g., C-II within state-mandated validity window; non-controls within 1 year).

Prescription Number (Rx #): Ensure unique serial number matches electronic filing and audit queues.

Drug Name & Strength: Verify generic name, brand reference, active strength, and unit markers (e.g., 50 mcg vs. 50 mg; 10 mg/5 mL vs. 20 mg/5 mL).

Dosage Form: Confirm release mechanism and form (e.g., Metoprolol Succinate ER vs. Tartrate IR; Ointment vs. Cream).

Directions for Use (SIG): Must contain an active verb ( Take , Instill , Inhale , Apply , Inject ), clear dose, explicit route ( by mouth , into right ear , subcutaneously ), and precise frequency ( twice daily , every 8 hours ). Avoid ambiguous abbreviations.

Quantity Dispensed: Confirm exact pill count, liquid volume, or tube size matching third-party billing.

Refills Remaining: Verify remaining refills against legal caps (C-II = 0 refills; C-III–IV = max 5 refills within 6 months; non-controls = max 1 year).

Standardized NDC & Manufacturer: Match 11-digit NDC and manufacturer against stock packaging.

Beyond-Use Date (BUD): Verify BUD on outpatient vials (typically 1 year from dispensing date or manufacturer expiration, whichever is shorter) and specialized BUDs for reconstituted liquids/insulins.

Cautionary & Auxiliary Statements: Confirm mandatory federal controlled substance transfer label ( "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed" on C-II through C-IV) and necessary auxiliary warning stickers ( Take with food , Avoid sunlight , Shake well , Refrigerate ).

4. Systematic Final Verification Clearance Workflow

To eliminate cognitive fatigue and blind visual scanning, verifying technicians must follow a structured 4-step physical verification sequence : ┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐

  • │ Step 1: │ │ Step 2: │ │ Step 3: │ │ Step 4: │
  • │ ORDER vs LABEL │ ────> │ LABEL vs STOCK │ ────> │ STOCK vs DOSE │ ────> │ PACKAGING & │
  • │ (Hardcopy/EHR) │ │ (Bottle NDC) │ │ (Pill Imprint) │ │ AUXILIARY TAGS │
  • └─────────────────┘ └─────────────────┘ └─────────────────┘ └─────────────────┘
  • Hard-Stop Criteria

If ANY of the following discrepancies are identified during verification, the technician must execute an immediate Hard Stop , quarantine the medication basket, and escalate according to pharmacy protocol:

  • NDC mismatch (Segment 1 or 2)
  • Expired stock or BUD calculation discrepancy
  • Incorrect salt form, strength, or modified-release designation
  • Pill physical appearance / debossed imprint mismatch
  • Missing required federal controlled substance warning or critical auxiliary label

Ambiguous, conflicting, or missing SIG directions.

Loading diagram... Systematic 4-Step Final Product Verification Clearance Sequence